Drugs / V114-A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02547649 | Oct 2015 → Jan 2016 | pneumococcal infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V114-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02547649 ↗ |
| Route | Intramuscular | “Participants receive a single 0.5 mL intramuscular injection of V114 Formulation A on Day 1” NCT02547649 ↗ |